Human Performance Laboratory
Austin, Texas, 78712, United States
NCT Number: NCT03258346
A research study regarding the body's response to several weeks of training using short sprints and pomegranate juice supplementation
Looking for future studies?
Notify Me50 year–70 year
All sexes
Interventional
Not applicable
Austin, Texas, 78712, United States
The investigators have shown that chronic pomegranate juice consumption in both young untrained and weight-trained men partially protects muscles against the damage done from performing high intensity eccentric contractions and that it accelerates recovery of function. Clearly, skeletal muscle is a target for some of the healthful molecules in pomegranate juice. However, the most widespread and serious ailment to strike skeletal muscle is sarcopenia (e.g.; loss of muscle mass and becoming 'frail') with age due predominantly to a loss of 'fast-twitch' muscle fibers. Since adults rarely sprint or exert maximal force or power, they rarely use their fast-twitch muscle fibers, which thus degenerate greatly with age. Usually, about one-half of a person's muscle fibers are fast-twitch. It is the investigators' hypothesis that the combination of power exercise training and pomegranate juice supplementation (POM) over 10 weeks, will elicit greater improvements in maximal muscular power and functional physical abilities compared to power training with a placebo. The investigators also will identify changes in size and composition of leg muscles (MRI) and of the whole body (DEXA). The investigators simple logic is that muscles deteriorate with age because they are 'turned-off' and that exercise training can turn them 'back-on', but in order for the muscle fibers to fully repair when turned 'back-on' with exercise, they might benefit from agents known to foster repair, such as the natural polyphenols in pomegranate juice. It has recently been found that polyphenols are metabolized into urolithins which improve muscle cell function due to increased mitophagy. The investigators aim to determine if power training and pomegranate juice have additive effects in promoting improvements of muscle function and mass in men and women age 50-70 y.
A second purpose is to include a cardio-metabolic exercise training stimulus into the workout without compromising the efficacy of the power training. One feature of cardio-metabolic training is an increase in muscle mitochondria and oxygen utilization which might improve muscle fiber repair. The 'power training' will consist of maximal effort 4 sec sprints on a cycle ergometer with no added resistance with the only load being that of the inertia of the flywheel as the subject accelerates from 0 to their maximal RPM's while cycling (100-150 RPM)('inertial load ergometer'; ILE). The power training will be accomplished by having the subject complete 15-30 sprints in a 15 min period. During the training bouts, initially the subjects will rest 56 s between sprints (week 1- complete 15 sprints in each15 min bout), and then 41 s between sprints (weeks 2-5 and complete 20 sprints) and finally 26 s between sprints (weeks 6-10 and complete 30 sprints). The shorter rest periods (41 s and 26 s) will result in incomplete recovery of the cardio-respiratory system and thus the oxygen consumption and heart rate will average 50-70% of maximal values, which is a similar intensity as jogging, but without the jarring of foot strike.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each session of training will require a total of 15 min with the total time actually exercising of only 60-120 sec. The first week will consist of performing 15 'sprints' on the ILE, beginning each sprint with 56 sec of rest. During week 2-5, subjects will rest 41 sec between sprints, completing 20 bouts. Finally, during weeks 6-10, subjects will take 26 s rest between sprints and complete 30 bouts).
Other names: High intensity interval training
Subjects will consume 8oz of pomegranate juice daily for duration of study.
Subjects will consume 8oz of pomegranate juice daily, that has had the polyphenols removed.
Time frame: Baseline to 11 weeks
Volume of the thigh musculature as determined by MRI analysis.
Time frame: Baseline to 11 weeks
Intermuscular adipose tissue infiltration as measured by MRI
Time frame: Baseline to 11 weeks
VO2 Max on a cycle ergometer
Time frame: Baseline to 11 weeks
The percent of maximal aerobic capacity that a subject can exercise at while not building up blood lactate
Time frame: Baseline to 11 weeks
Muscle aerobic stress as measured by near infrared spectroscopy
Time frame: Baseline to 11 weeks
Fat and fat free regional and total mass as measured by dual x-ray absorptiometry
Time frame: Baseline to 11 weeks
The ability to produce power as determined on the cycle ergometer and measured in watts
Time frame: Baseline to 11 weeks
Flow mediated dilation and pulse wave velocity
Time frame: Baseline, 2 hrs after consuming first pomegranate or placebo supplement
The ability to breakdown the beneficial components of pomegranate juice into urolithins is different among individuals
Time frame: Baseline, week 10 and week 15
The change in the gut microbiota as a result of supplementation with pomegranate juice.
Time frame: Baseline to 11 weeks
The maximal ability to push against a immovable object as measured in the thigh musculature
Time frame: Baseline to 11 weeks
Movement tasks specific to the daily life of the elderly
Time frame: Baseline to 11 weeks
The subject will exert maximal leg extension at two speeds and the maximal torque generated will be quantified
University of Texas at Austin
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07580144
Atrophy, Frailty
Konya, Turkey (Türkiye)
View Trial DetailsNCT06629805
Atrophy, Muscular Atrophy
Yangsan, South Korea
View Trial DetailsNCT07629063
Atrophy, Basal Ganglia Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07716839
Aging, Atrophy
Montes Claros, Minas Gerais, Brazil
View Trial Details